Highbridge Capital Management
North America, New York, United States, New York
Description
HCM is a global alternative investment management firm launched in 1992. Since its inception, the company has developed a diversified
Investor Profile
Highbridge Capital Management has backed more than 29 startups, with 1 new investments in the last 12 months alone. The firm has led 13 rounds, about 45% of its total and boasts 19 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Debt, Post Ipo Equity, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, Israel.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Led 1 rounds in the past year.
Stage Focus
- Post Ipo Debt (48%)
- Post Ipo Equity (17%)
- Series Unknown (14%)
- Private Equity (7%)
- Convertible Note (3%)
- Debt Financing (3%)
- Series C (3%)
- Series B (3%)
Country Focus
- United States (52%)
- Switzerland (14%)
- Israel (14%)
- United Kingdom (7%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Belgium (7%)
- Ireland (3%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
- Australia (3%)
'/%3e%3c/defs%3e%3cpath fill='%23012169' d='M0 0h10080v5040H0z'/%3e%3cpath stroke='%23fff' stroke-width='.6' d='m0 0 6 3m0-3L0 3' clip-path='url(%23b)' transform='scale(840)'/%3e%3cpath stroke='%23e4002b' stroke-width='.4' d='m0 0 6 3m0-3L0 3' clip-path='url(%23c)' transform='scale(840)'/%3e%3cpath stroke='%23fff' stroke-width='840' d='M2520 0v2520M0 1260h5040'/%3e%3cpath stroke='%23e4002b' stroke-width='504' d='M2520 0v2520M0 1260h5040'/%3e%3cg fill='%23fff'%3e%3cuse xlink:href='%23d' x='2520' y='3780'/%3e%3cuse xlink:href='%23a' x='7560' y='4200'/%3e%3cuse xlink:href='%23a' x='6300' y='2205'/%3e%3cuse xlink:href='%23a' x='7560' y='840'/%3e%3cuse xlink:href='%23a' x='8680' y='1869'/%3e%3cuse xlink:href='%23e' x='8064' y='2730'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Manufacturing
- Medical Device
- Therapeutics
- Software
- Medical
- Oncology
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Highbridge Capital Management frequently co-invest with?
What are some of recent deals done by Highbridge Capital Management?
Find More Investors Like Highbridge Capital Management
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
